Study Objective To characterize the mutational landscape of endometriosis and eutopic endometrium and to evaluate how clonal genomic alterations may influence disease pathogenesis, lesion heterogeneity, and surgical management strategies. Design Narrative synthesis of genomic studies investigating somatic mutations in endometriosis and eutopic endometrium. Setting Comprehensive analysis of molecular and genomic studies relevant to minimally invasive endometriosis surgery and lesion biology. Patients or Participants Included studies analyzed endometriotic lesions and eutopic endometrium from women with surgically confirmed endometriosis. Genomic profiling was performed using targeted next-generation sequencing, whole-exome sequencing, or whole-genome sequencing. Many studies applied laser-capture microdissection or single-gland isolation to characterize epithelial clonal architecture. Interventions Molecular analyses focused on identifying recurrent somatic mutations and evaluating their biological effects on proliferation, inflammation, oxidative stress responses, and fibrogenesis within endometriotic lesions and eutopic endometrial tissue. Measurements and Primary Results Recurrent somatic mutations in ARID1A, PIK3CA, KRAS, and PTEN were consistently identified across ovarian, deep infiltrating, and peritoneal endometriosis. Iron-driven oxidative stress, frequently linked to retrograde menstruation, contributed to DNA damage, lipid peroxidation, and mitochondrial dysfunction. Despite iron overload, endometriotic cells demonstrated resistance to ferroptosis, facilitating lesion survival in an iron-rich microenvironment. Oxidative stress also promoted fibroblast activation, extracellular matrix deposition, epithelial–mesenchymal transition, and progressive fibrosis. Importantly, genomic studies revealed that histologically normal endometrium frequently harbors oncogenic mutations with age-dependent clonal expansion generating spatially distinct epithelial clones. These mutated epithelial populations may serve as cellular reservoirs for ectopic implantation and lesion formation. Conclusion Somatic mutations are a fundamental component of the molecular architecture of both eutopic endometrium and endometriosis. Recognition of clonal heterogeneity and mutation-driven lesion evolution has important implications for surgical management, including lesion mapping, completeness of excision, and strategies aimed at reducing recurrence after minimally invasive endometriosis surgery.
The guidelines for standardizing approaches to providing adequate nutrition for pregnant women, nursing mothers, and young children were developed in accordance with the President’s List of Instructions following a State Council meeting on social support for families in the Russian Federation. The guidelines aim to improve the regulatory framework and enhance the effectiveness of organization of adequate nutrition for the above-mentioned categories of citizens, consistent with the priority areas of state policy in the field of maternal and child health. The document provides a systematic overview of the organizational, managerial, regulatory, and medical aspects of providing adequate nutrition to target population groups. Particular attention is given to unifying the legal frameworks, including the development of a multi-level system of regulatory acts, as well as allocation of powers among the executive bodies of constituent entities of the Russian Federation. The recommendations address financial and economic support, proposing a methodology for calculating the standard financial support per recipient. This enables the constituent entities of the Russian Federation to plan budget allocations taking into account regional specificities. Since the stated social support standard is implemented based on a physician’s opinion, is regionally specific, and is implemented in accordance with the legislation of the constituent entities of the Russian Federation, the document is recommended for use by the executive authorities of the constituent entities when developing and improving regulatory acts and programs for organizing the provision of adequate nutrition for pregnant women, nursing mothers, and young children.
Study Objective To evaluate the effectiveness of hyaluronic acid–based adhesion barriers in reducing postoperative adhesions after pelvic surgery using a controlled experimental model and to integrate these findings with clinical evidence. Design Experimental animal study combined with systematic review and meta-analysis of clinical trials. Setting Experimental surgical laboratory and tertiary referral center for minimally invasive gynecologic surgery at the National Medical Research Center for Obstetrics, Gynecology and Perinatology. Patients or Participants Female Wistar rats were used in a standardized experimental model of postoperative adhesion formation. Animals were randomly assigned to control and intervention groups following induction of surgical trauma to the uterine horns. Interventions A standardized pelvic surgical injury model was created to induce adhesion formation. In the intervention group, a hyaluronic acid–based anti-adhesion gel was applied intraperitoneally to traumatized peritoneal surfaces immediately after surgery. Adhesion formation and tissue healing were assessed using histological and ultrastructural analyses. To contextualize these findings, a systematic review and meta-analysis of clinical studies evaluating hyaluronic acid adhesion barriers in gynecologic surgery was performed. Measurements and Primary Results In the experimental model, hyaluronic acid application significantly reduced inflammatory cell infiltration, fibroblast activation, and collagen deposition compared with controls, resulting in a marked reduction in dense adhesions while preserving physiologic tissue regeneration. Meta-analysis of randomized clinical studies demonstrated that hyaluronic acid barriers significantly reduce the incidence, severity, and surface area of postoperative adhesions after procedures such as myomectomy, endometriosis surgery, and adnexal surgery. The protective effect is mediated by temporary separation of traumatized peritoneal surfaces during early wound healing, limiting fibrin deposition and fibrotic adhesion formation. Conclusion Experimental and clinical evidence demonstrates that hyaluronic acid–based adhesion barriers effectively reduce postoperative adhesion formation. Their routine use during minimally invasive gynecologic surgery may improve surgical outcomes and reproductive prognosis.
Study Objective To evaluate the antifibrotic potential of bovhyaluronidase azoximer (BHA), a modified hyaluronidase, in experimental models of endometriosis-associated fibrosis and to explore its role in preventing fibrosis and adhesions that complicate surgical management of endometriosis. Design Combined experimental study using in-vitro fibroblast models and an in-vivo rat model of endometriosis. Setting Experimental laboratory and preclinical research platform supporting translational studies relevant to minimally invasive gynecologic surgery. Patients or Participants In-vitro experiments utilized NIH/3T3 fibroblasts stimulated with TGF-β1 to induce a fibrotic phenotype. In-vivo experiments were conducted in Wistar rats with surgically induced endometriosis created by autologous endometrial transplantation. Interventions Fibroblasts were stimulated with TGF-β1 (5 ng/mL) to induce myofibroblast differentiation. BHA (3–30 U/mL) was administered either concurrently (prevention model) or after differentiation (treatment model). Expression of collagen I, α-SMA, CCN2, CD44, TGF-β1, and CCL5 was assessed by qPCR. Cellular metabolic activity and migration were evaluated using MTT and scratch assays. In-vivo, animals received intramuscular BHA at 900 or 1800 IU/kg every three days. Lesion volume, adhesion formation, and expression of fibrotic and inflammatory markers were evaluated. Measurements and Primary Results BHA significantly suppressed TGF-β1–induced collagen I expression, reduced fibroblast metabolic activity, and inhibited cell migration. In differentiated myofibroblasts, BHA decreased expression of TGF-β1, CD44, and CCL5. In-vivo, BHA at 900 IU/kg reduced lesion volume (12.9 mm³ vs 17.0 mm³ in controls), decreased adhesion formation, and downregulated TGF-β1, α-SMA, CD44, and inflammatory cytokines. The higher dose (1800 IU/kg) produced less consistent effects. Conclusion BHA demonstrates antifibrotic activity by modulating TGF-β1–driven fibrogenesis and inflammation in experimental endometriosis. These findings support further investigation of BHA as a non-hormonal strategy to reduce fibrosis and adhesion formation and potentially improve surgical outcomes after endometriosis surgery.
relevance: Patients with morbid obesity undergoing general anesthesia for laparoscopic surgery are highly sensitive to complications, including transient hypoxemia, hemodynamic instability, delayed awakening, opioid hypersensitivity, postoperative pulmonary complications, and postoperative nausea and vomiting. Optimization of anesthesia management without opioids remains an important clinical challenge. CASE DESCRIPTION: A 35-year-old female patient (height 164 cm, weight 180 kg, body mass index 66.9 kg/m2) underwent robot-assisted hysterectomy for recurrent endometrial hyperplasia under combined anesthesia (general anesthesia with epidural analgesia). The mean qCON (consciousness index) during surgery was 50.2. The analgesic component of anesthesia was achieved through epidural administration of 0.1% ropivacaine hydrochloride solution, 10 mL every 30 minutes, at an infusion rate of 250 mL/hour during bolus delivery. The mean qNOX (nociception index) was 29.8. The mean total duration of qNOX peaks was 98.2 seconds over the 2 hours 35 minutes of surgery. Intraoperative hemodynamics were stable: blood pressure ranged from 120/70 to 140/80 mm Hg, heart rate 70–80 bpm, and SpO2 98–100%. Muscle relaxation was not maintained by additional administration of rocuronium bromide due to adequate relaxation of the abdominal wall and absence of inspiratory triggering from the patient. The TOF neuromuscular transmission ratio ranged from 40% to 50%, and electromyography (EMG) values ranged from 10 to 25, indicating adequate relaxation of the anterior abdominal wall muscles. The postoperative period was uneventful. The patient was discharged on postoperative day 6 in satisfactory condition with no active complaints. CONCLUSION: In this clinical case, the chosen anesthesia management tactic provided effective analgesia and enabled early mobilization of the patient.